Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of SGLT2 Inhibitor on Type 2 Diabetic Patients Undergoing Cardiac Surgery

NCT04340908 is registered in ClinicalTrials.gov with Hongchang Guo as lead sponsor.

NCT NCT04340908
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04340908 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of SGLT2 Inhibitor on Type 2 Diabetic Patients Undergoing Cardiac Surgery
Lead sponsor
Hongchang Guo
Phase
Phase 4
Overall status
Unknown status
Start date
January 1, 2021
Completion date
June 1, 2023
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac surgery, diabetes mellitus, type 2